The VA Office of Inspector General (OIG) reviewed the Opioid Safety Initiative (OSI) oversight processes at the VA Northern California Health Care System (facility).In an effort to evaluate the effectiveness of OSI oversight processes at the Veterans Health Administration (VHA), the OIG reviewed data of numerous providers across VHA. Several providers assigned to the facility’s Sacramento VA Medical Center were identified as prescribing “high dose” opioids. The OIG conducted a review of opioid therapy management practices by patient aligned care team providers (providers) and supervisors (supervisors) at the facility, in addition to facility and Veterans Integrated Service Network (VISN) oversight processes for opioid therapy.The OIG determined that supervisors ensured that providers received training on OSI. Facility providers and supervisors implemented safe opioid therapy prescribing practices, including completing informed consents. Facility providers and supervisors completed risk mitigations for patients receiving opioid therapy, including state prescription drug monitoring and urine drug screens. For calendar year 2021, facility completion rates for patients prescribed opioid therapy met or exceeded the VISN performance goal for informed consents (97 percent), state prescription drug monitoring (99 percent), and urine drug screens (89.8–93.9 percent).Facility providers had knowledge of VHA recommendations for a pain assessment to be completed every three months, with a completion rate of 73.6 percent over the last 100 days during the inspection.Facility and the VISN had staff, committees, and teams as required to provide oversight and support integration of the OSI into primary care.The facility did not have a required policy providing local guidance on state prescription drug monitoring and the facility pain management policy provided outdated guidance. The Facility Director concurred with the OIG’s two recommendations related to creating and updating the policies.
| Report Date | Agency Reviewed / Investigated | Report Title | Type | Location | |
|---|---|---|---|---|---|
| Department of Veterans Affairs | Opioid Safety at the VA Northern California Health Care System in Mather | Inspection / Evaluation |
|
View Report | |
| Securities and Exchange Commission | Deputy Inspector General for Audits, Evaluations, and Special Projects’ Testimony before the Committee on Financial Services Subcommittee on Oversight and Investigations, U.S. House of Representatives, March 8, 2023 | Other | Agency-Wide | View Report | |
| Department of the Treasury | Roll-up of the Independent Review of 4003(b) Loan Recipients’ Validation Memos Audit Memorandum Number SIGPR-A-22-003-17 | Audit | Agency-Wide | View Report | |
| Internal Revenue Service | Additional Actions Are Needed to Improve and Secure the Income Verification Express Service Program | Audit | Agency-Wide | View Report | |
| Department of Commerce | Capstone Report: Effective Reviews Are Needed to Enhance the Security Posture of the Department’s Active Directories | Audit | Agency-Wide | View Report | |
| Department of Justice | Review of the U.S. Department of Justice’s Accounting of Drug Control Funding Fiscal Year 2022 | Review | Agency-Wide | View Report | |
| Department of Justice | Audit of the Federal Bureau of Investigation Annual Financial Statements Fiscal Year 2022 | Audit | Agency-Wide | View Report | |
| General Services Administration | GSA Misled Customers on Login.gov’s Compliance with Digital Identity Standards | Inspection / Evaluation | Agency-Wide | View Report | |
| Department of Veterans Affairs | Independent Review of VA’s Special Disabilities Capacity Report for Fiscal Year 2021 | Review | Agency-Wide | View Report | |
| National Science Foundation | Law Enforcement Perspectives on Sexual Assault and Stalking Issues Pertaining to the United States Antarctic Program | Other |
|
View Report | |